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Abstract  
High intensity lasers have been shown to accelerate protons to high energies.  
These protons are energetic enough to be used in treating cancers and tumors 
up to three centimeters deep.  Protons are advantageous to use because they 
do not cause as much damage to healthy cells in the body then other 
radiation sources, e.g. photons.  Simulations using MCNP show the radiation 
dose received by an intraocular melanoma would require 10
6
 protons to 
deliver a dose of 1.2 Gy to the tumor.  The simulations also show that 
protons do a better job of giving less dosage to healthy cells compared to the 
same dose delivered using x-rays.  Further research needs to be done to find 
ways to accelerate protons to higher energies.  
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I. Introduction  
Radiation therapy is a proven method of killing cancers and tumors inside of the 
body. Radiation therapy can be achieved through the use of x-rays, photons, protons, as 
well as heavy ions. Radiation therapy works by external particles (or protons) interacting 
with cell structure in the body, causing excitation and ionization. The released charged 
particles have the ability to destroy the cancer cell’s DNA. If the DNA has been 
significantly altered, so the cell can no longer replicate, it is considered to be destroyed. 
Since the applied radiation will irradiate all cells, for therapy to be effective, the risk of 
irradiating healthy cells must be minimized while maximizing the damage done to the 
cancerous cells [1]. 
 Wilson, in 1946, first proposed using protons as an effective method of radiation 
therapy. The first medical case treated with protons was a pituitary tumor in 1954. There 
are many advantages for using protons for therapy: unlike x-rays and photons each of 
which will give a large dose of radiation to the healthy cells on its path to the tumor, the 
dose deposited by the proton while traveling through healthy tissue is smaller. The 
protons give off the majority of their energy at the end of their path. This is denoted by 
the Bragg Peak (see figure. 1). The distance the protons travel is determined by their 
initial energy. By using a modified Bragg Peak, one can select a range of proton energy 
and a range of distance by which to deposit dosage. Another reason for using proton 
therapy is protons are deflected less than electrons. Because the protons are more massive 
in size, the momentum transfer from hitting cells is less likely to cause a change in 
direction. This means when the protons are traveling through tissue the protons will stay 
collimated and will not diverge and deposit their energy into healthy cells. Using protons 
for radiation therapy gives great control so energy can be deposited into exact locations 
within the tumor. [2]. 
2 
 
 
Figure 1 Plot of dose deposited in water as a function of distance for 6 MeV photons and 150 MeV protons.  For 
example, if the tumor was located 20 to 25 cm into tissue, the dosage at the tumor would be maximized with 
protons while decreasing the dosage to healthy cells that the photon beam would distribute. 
 
 
II. Proton Energy Requirements  
Basic requirements for using protons include control of the proton energy, control 
over energy selection, collimation of the beam, and control of the number of protons 
delivered with requirements for steering the protons to the patient. In order for protons to 
reach tumors deep inside the body, the proton energies must reach 230-250 MeV. One eV 
is the amount of energy it takes for one proton to travel across an electric potential of 1 
volt. Therefore, 230-250 MeV is equivalent to 3.7 x 10
-11
 to 4 x 10
-11
 J. The beam 
requirement for selecting specific energy ranges is necessary to control the depth at 
which the protons deposit their energy.  The range of protons delivered should be enough 
to reach the depth of the tumor without excessive radiation dosages being received by the 
healthy cells surrounding the tumor. The collimation of the beam allows for precise 
placement of energy into the patient, avoiding healthy cells around the tumor. The 
number of protons delivered must be controlled in order to control the radiation dosage 
received to the tumor cells. Other requirements for radiation therapy delivery systems are 
steering the protons to the patient while minimizing patient discomfort, and providing the 
proper shielding from other radiation products produced [3] [4]. 
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Research in physics recently discovered that proton beams can be generated by a 
high intensity laser hitting a metal target. High intensity lasers are less expensive, costing 
tens of millions of dollars as opposed to over $100 million. High intensity lasers also are 
more compact. The lasers would have the ability to fit into a hospital wing, as opposed to 
needing a whole building dedicated to proton therapy treatment [5]. The savings in cost 
and space would make proton therapy more affordable to medical facilities, ultimately 
increasing the availability of radiation therapy treatment for those with cancer.  
 
 
III. Accelerating Protons: Target Normal Sheath Acceleration 
One method to accelerate protons from a laser source is Target Normal Sheath 
Acceleration (TNSA) (Figure 2). In this process, an intense laser (10
18
 W/cm
2
) hits a 
target. The energy of the laser is transferred to the target. Because the electrons in the 
target are less massive than protons, the electrons will accelerate faster than the protons 
in the target and will achieve greater speeds than the protons. Some of the electrons 
escape off the back of the target. As this occurs, the target will become positively charged 
and the electrons that escape will stay on the back target, creating a layer called the 
Debye Sheath. The electric force attracts protons and accelerates the protons off of the 
back of the target. The protons accelerating off the back of the target are collimated 
because of the electric force created by the electrons [6].    
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Figure 2 The laser pulse hits the front of the target creating the preplasma and the hot electrons. The hot 
electrons are driven out of the target setting up a Debye Sheath, which creates electric fields. The electric fields 
accelerate the protons. This is not to scale. 
Obstacles for the immediate construction of this instrument include the need to 
increase the number of protons generated at higher energies. Currently lasers in operation 
are able to achieve proton energies of up to 60 MeV [7]. This energy would not be great 
enough to treat most types of tumors or cancers which require 50-250 MeV. As proton 
energy is increased the number of protons produced will also have to increase so that the 
tumor will receive a high enough dose to destroy tumor cells. 
 
 
IV. Relevance 
The proton energy needed to treat an eye tumor 2 cm deep is 50 MeV. This 
converts to 8 x 10
-12 
Joules.  An eye tumor with mass of 1 gram requires a dose of 60 
Gray which would be a total of 10
10 
MeV. The dose deposited per minute is 1-2 Gy, 
which translates to 2 x 10
8 
protons per shot of 50 MeV, or 8 x 10
-12 
J, protons [7]. This 
estimate uses approximations including that all of the protons are deposited at the Bragg 
Peak and that all of the protons are monoenergetic. According to Snavely’s paper [8] on 
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experiments from the NOVA pettawatt-laser, which has since been dismantled, one shot 
from the laser can produce as many as 7 x 10
9 
protons of 50 MeV for a single laser shot 
[8]. Therefore, with current laser technologies it is feasible to deliver a dosage that could 
treat cancers just a few cm under the skin.  
Laser acceleration of protons would be a cost effective solution to proton therapy 
treatment. The successful results of this research would increase the fiscal opportunity for 
more facilities to be able to provide radiation therapy to patients with cancer. 
 
 
V. Goals 
 The goal of this research is primarily to show through simulations using the 
particle transport code Monte Carlo N-Particle, code optimized for protons (MCNPX), 
that a proton source can target and treat a tumor a few cm into the eye.  The proton source 
in the simulation will resemble the size and amount of protons generated from a laser 
shot.  The eye will initially be modeled as a body of water with its surrounding bone and 
tissue in order to accurately calculate the dosage deposited in the tumorous region and the 
collateral damage that will occur to healthy material surrounding the tissues. The bone, 
skin, and tissue modeled have the correct molecular ratios and stoichiometry in the 
MCNP simulation. 
 MCNP is a Monte Carlo code that is able to simulate particle interactions.  The 
user must input the source particles including what type and what energies, and the 
material that the source particles interact with.  The code will send in one source particle 
at a time and determine different aspects of it behavior in the material including the path 
of the source particle, flux through user defined surfaces, and energy deposited in 
different areas.  After running many source particles through the material the Monte 
Carlo code is able to determine the average behavior of the particles and give a 
distribution of the behavior per particle.   
 
 
VI. Results 
 A simulation was run using MCNPX with a 50 MeV uniform disc source, radius 
0.5 cm, generating 100,000 protons shot into a cylinder of water.  The protons generated 
were all traveling normal to the plane of the source.  The cylinder of water had a radius of 
5 cm and was broken into section every tenth of a cm for a total of 4 cm of water (see 
figure 3).  The simulation calculated the amount of energy deposited in each tenth cm of 
water in MeV/gram. 
              
6 
 
 
Figure 3 Simulation set up in MCNPX of a 50 MeV proton disc source and a cylinder of water partitioned every 
tenth of a centimeter. 
 The simulation results were graphed and the results are shown below in figure 4.  
The peak of the protons occurs in the volume from 2.1 to 2.2 cm deep into the cylinder.  
This agrees with the results of Konefal for 50 MeV protons [9]. 
 For 10,000 protons at 50 MeV a dose of 0.00017 Gy will be deposited to the 
tumor.  This means for the 7x10
9
 protons at 50 MeV seen in Snavely’s paper there would 
be a dose of 200 Gy to a tumor which would be one hundred times bigger than the dose 
needed to treat it.  
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Figure 4 Simulation result of MCNPX showing the Bragg peak in water with depth of 2.1 to 2.2 cm 
 
 
The next simulation used a crude model of a head to find the dosage a 58 MeV 
source would input into an intraocular tumor (see figure 5).  The intraocular tumor was 
modeled for the dimensions of a large intraocular melanoma [10]. The density and atomic 
makeup of the materials in the simulation were found in the thesis “Medical Physics 
Calculations with MCNP
TM:  A Primer” [11] with the exception of the eye and tumor.  
The eye was estimated to be water and the tumor to be soft tissue [12]. The eye is 4.8 cm 
in diameter and the tumor is estimated to be a cylinder with a diameter of 2 mm and 5 
mm in depth.  
 
 
Figure 5 Geometry of the simulation. The light blue is the eye with the green tumor inside. Blue is skull, yellow is 
skin, red brain, green is soft tissue, pink is air. 
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 The source was 5 cm to the left of the eye and collimated with a single energy of 
58 MeV.  The diameter of the source is 10 microns which is the approximate size of the 
proton beam accelerated from the laser TNSA interaction.   
 The simulation ran for 1x10^6 protons and the resulted in 1.2 Gy deposited into 
the tumor.  The next highest dose deposited was the region directly in front of the tumor 
which received a dosage of 0.13 Gy.  Overall there was a total dose of less than 2 Gy 
deposited in the whole structure.  The dosage for most of the areas including the skull, 
skin, and parts of the eye that was not in a direct line from the source received doses of 
less than a microGray. The brain received no dose from the protons. 
 This can compare to a simulation done with 20 MeV photons.  For the same 
amount of dose to be received by the tumor the dose to the eye, skin, and skull all 
increase by a factor of three. In the photon simulation the brain will receive a dose of 0.3 
mGy. However, this dose is for the whole brain and most of the energy will be deposited 
in the line of the photon beam therefore a dose of higher than 0.4 mGy should be 
expected for that area. 
 Plots of the particles going through the head are shown below the points that 
appear on the plot are the places where the particles, either the protons or the photons, 
deposit energy into the head.  Figures 6 and 7 show the particle tracks for 1000 protons 
going into the eye. It can be seen that there is some dispersion but the majority of the 
energy is indeed deposited into the tumor. Figure 8 shows the particle tracks for 1000 
photons entering the skull.  The figure clearly shows that the photons will go through the 
brain deposit energy throughout it. 
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Figure 6 Particle tracks of 1000 protons through the skull. 
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Figure 7 Close up picture of proton particle energy deposited in the eye. 
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Figure 8 Locations of energy deposited by 1000 x-rays through the skull. 
 
Another simulation was run in MCNP to determine the distribution of dose through the 
skull in line with the source. For this simulation a cylinder with a diameter of 2 mm was inserted 
through the skull with in line with the path of source particles.  This cylinder was partitioned 
every millimeter and the dose of each millimeter partition was determined for both the proton and 
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x-ray cases.  This plot is shown in figure 9.  In this figure both the proton and s-rays will give a 
total tumor dose of 1.2 Gy. The figure clearly shows that protons will give a smaller dose to all 
areas surrounding the tumor and that protons are much more effective at protecting the brain, and 
in fact the protons give the brain no dose.  
 
 
 
Figure 9 Dose deposited by both protons and photons that give a whole tumor dose of 1.2 Gy. 
  
 
VII. Conclusion  
Having a means to treat cancers and tumors up to 3 cm deep in the body without causing 
much damage to surrounding areas, and more importantly causing almost no damage to cells 
behind the tumor has major implications to treating tumors. 
 It has been shown that protons accelerated by lasers can create a dosage of 1.2 
Gy with 10^6 protons.  The amount of 58 MeV protons seen in one laser shot by Snavely was 1 x 
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10^9. This means that one laser shot could conceivably deliver a dosage of much greater than the 
60 Gy required to treat an eye tumor so patients will need fewer radiation treatments. 
The next step in the study is to have the source come in at multiple angles to try and find 
the smallest dosage possible to the surrounding structures for a maximum dose to the tumor.  
Another simulation to be done is the have a larger tumor and have a proton source of multiple 
energies so that an even dosage will be deposited throughout the tumor.  
Other scientists have considered different systems to separate single energies from the 
protons created by the laser and for the gantry systems that would deliver the protons to the 
patients. 
An example of separating different proton energies was developed Ma at Fox Chase 
Cancer Center [13]. The protons from the laser target interaction would go enter a collimator and 
enter a series of magnets.  The amount that the protons would bend can be determined knowing 
the magnetic field of the magnets. The protons would enter an energy selector where only the 
specific energies needed for treating the tumor would be selected and the rest of the proton 
energies would be absorbed.  The protons would then return through a series a magnets and exit 
through a second collimator and then would be used for treatment.  This configuration is shown 
in figure 8. 
 
 
Figure 10 An example of a proton energy selector by Ma from Fox Chase Cancer Center. 
 Different gantry systems have been modeled to show how a patient would be orientated 
during treatment [14].  The systems have a laser with light steered to the patient. Very near the 
patient is the target interaction.  By having the patient close to the laser it minimizes the cost of 
having to steer the protons with large magnets.  After the laser target interaction it the protons 
will enter into an energy selector and then be delivered to the patient (see figure 9).  With this 
system one laser can treat multiple patients in different rooms. The laser light could be steered to 
different target areas for each patient room with mirrors, again minimizing the cost of the facility.  
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Figure 11 Possible gantry system showing the laser light steered to the patient treatment room 
 
 For laser accelerated protons to be a viable option for treating all types of cancers and 
tumors further research needs to be done to find ways to increase the proton energies up to at least 
250 MeV. However, it is shown that for cancers up to 3.5 cm deep in the eye protons current laser 
accelerated protons energies would be sufficient for the treatment of those tumors. 
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